-Universitätsklinikder

86
Sladden, M. J., Balch, C., Barzilai, D. A., Berg, D., Freiman, A., Handiside, T.,
Hollis, S., Lens, M. B. and Thompson, J. F. (2009). Surgical excision margins
for primary cutaneous melanoma. Cochrane Database of Systematic
Reviews 4
Sørensen, R. B., Junker, N., Kirkin, A., Voigt, H., Svane, I. M., Becker, J. C.,
Becker, J. C., Straten, P. T. and Andersen, M. H. (2009). The
immunodominant HLA-A2-restricted MART-1 epitope is not presented on the
surface of many melanoma cell lines. Cancer Immunology, Immunotherapy
58(5), 665–675
Statius Muller, M. G., van Leeuwen, P. A., de Lange-De Klerk, E. S., van
Diest, P. J., Pijpers, R., Ferwerda, C. C., Vuylsteke, R. J. and Meijer, S.
(2001). The sentinel lymph node status is an important factor for predicting
clinical outcome in patients with Stage I or II cutaneous melanoma. Cancer
91(12), 2401–8
Stolz, W., Schmoeckel, C., Landthaler, M. and Braun-Falco, O. (1989).
Association of early malignant melanoma with nevocytic nevi. Cancer 63(3),
550–5
Subramony, C. and Lewin, J. R. (1985). Nevus cells within lymph nodes.
Possible metastases from a benign intradermal nevus. American Journal of
Clinical Pathology 84(2), 220-223
Taube, J. M., Begum, S., Shi, C., Eshleman, J. R. and Westra, W. H. (2009).
Benign nodal nevi frequently harbor the activating V600E BRAF mutation.
The American Journal of Surgical Pathology 33(4), 568–71
Taylor, R. C., Patel, A., Panageas, K. S., Busam, K. J. and Brady, M. S.
(2007). Tumor-infiltrating lymphocytes predict sentinel lymph node positivity
in patients with cutaneous melanoma. Journal of Clinical Oncology : Official
Journal of the American Society of Clinical Oncology 25(7), 869–75
Thompson, J. F., Soong, S.-J., Balch, C. M., Gershenwald, J. E., Ding, S.,
Coit, D. G., Flaherty, K. T., Gimotty, P. A.,Johnson, T., Johnson, M. M.,
Leong, S. P., Ross, M. I., Byrd, D. R., Cascinelli, N., Cochran, A. J.,
Eggermont, A. M., McMasters, K. M., Mihm, M. C., Morton, D. L. and
Sondak, V. K. (2011). Prognostic significance of mitotic rate in localized
primary cutaneous melanoma: an analysis of patients in the multi-institutional
American Joint Committee on Cancer melanoma staging database. Journal
of Clinical Oncology : Official Journal of the American Society of Clinical
Oncology 29(16), 2199–205
Trefzer, U., Rietz, N., Chen, Y., Audring, H., Herberth, G., Siegel, P., Reinke,
S., Königer, P., Wu, S., Ma, J., Liu, Y., Wang, H., Sterry, W. and Guo, Y.
(2000). SM5-1: a new monoclonal antibody which is highly sensitive and